ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals

Stopped early · Not applicable

Conditions studied: Immunodeficiency, Immunosuppression, HIV Infections, Graft Versus Host Disease, Leukemia, Lymphoma, Cancer, Multiple Myeloma, Transplant, Age-Related Immunodeficiency

In brief

The investigators will examine whether a combination of at-home nucleic acid amplification tests, on-demand telemedicine, and delivery of prescriptions such as Paxlovid quickly after testing positive for COVID-19, can reduce severe outcomes and hospitalization of immunocompromised patients and those who are 65 years and older. They will also analyze whether these efforts lower the cost of care compared to standard of care.

Key facts

Study ID

NCT05655546

Run by

Scripps Translational Science Institute

People needed

2117

Starts

2022-12-22

Expected to finish

2024-06-20

Last updated by the study team

2025-08-08

Who can join

Age: 18 and older, up to 120. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Living in the United States
• 18 years or older
• Can read and understand English
• Use of smartphone with bluetooth, a camera and a compatible operating system (Android OS 9.0 or higher, Apple iOS 13.0 or higher)
• Vaccinated against COVID-19 (completed at least the initial course, e.g. at least 2 doses of -Moderna or Pfizer, one dose of J\&J)
• Willing and able to participate in study interventions including:
• Use of smartphone, including camera and bluetooth
• Upload verification of diagnosis, if needed
• Completing Surveys
• Use of Cue Health App
• Use of MyDataHelps Web or App
• Immunocompromised due to disease or therapy, including:
• Symptomatic HIV
• Graft versus host disease
• Immunoglobulin deficiency/Immunodeficiency
• Immunosuppressive therapy
• Leukemia
• Lymphoma (Hodgkin or non-Hodgkin)
• Metastatic Cancer
• Multiple Myeloma
• Solid organ malignancy
• Transplant, hematopoietic stem cell
• Transplant, solid organ
• Age 1. 65 years and older
• Option if under 65 to share claims data as a member of one of the following insurance providers:

You may not qualify if…

• Unable to meet inclusion criteria

Where it is running

• Scripps Research — La Jolla, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.